The Canadian Children Inflammatory Bowel Disease Network (CIDsCaNN)
Launched by THE HOSPITAL FOR SICK CHILDREN · Dec 4, 2014
Trial Information
Current as of September 01, 2025
Recruiting
Keywords
ClinConnect Summary
The Canadian Children Inflammatory Bowel Disease Network (CIDsCaNN) is a clinical trial aimed at understanding why inflammatory bowel diseases (IBD), such as Crohn's disease and ulcerative colitis, are becoming more common in children and teens in Canada. Researchers want to find out what environmental factors may contribute to these conditions and how they interact with a person's genetics. By studying a diverse group of children diagnosed with IBD, the trial will help identify the best treatment options and improve care for young patients across the country.
To participate in this trial, children aged 2 to 17 who have been diagnosed with IBD are eligible, as long as they or their guardians agree to take part. Participants can expect to be part of a study that not only looks at their symptoms but also tracks their growth and the healing of their intestines. The goal is to find out what works best for treating IBD in children, ensuring that they receive the best possible care.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • diagnosed with IBD - Crohn's, ulcerative colitis or inflammatory bowel disease undefined
- Exclusion Criteria:
- • Refusal to give informed consent
About The Hospital For Sick Children
The Hospital for Sick Children (SickKids) is a leading pediatric health care and research institution located in Toronto, Canada. With a commitment to advancing child health through innovative research, education, and clinical care, SickKids is recognized globally for its expertise in pediatric medicine. The hospital actively sponsors clinical trials aimed at improving treatment outcomes and enhancing the quality of life for children with various health conditions. By fostering collaboration among multidisciplinary teams and leveraging state-of-the-art facilities, SickKids strives to translate research findings into tangible advancements in pediatric care, ensuring that children receive the best possible treatments based on the latest scientific evidence.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Montreal, Quebec, Canada
Calgary, Alberta, Canada
Edmonton, Alberta, Canada
Montreal, Quebec, Canada
Ottawa, Ontario, Canada
Winnipeg, Manitoba, Canada
Toronto, Ontario, Canada
Vancouver, British Columbia, Canada
St. John's, Newfoundland And Labrador, Canada
Halifax, Nova Scotia, Canada
Brampton, Ontario, Canada
Hamilton, Ontario, Canada
London, Ontario, Canada
Patients applied
Trial Officials
Anne M Griffiths, MD, FRCPC
Principal Investigator
The Hospital for Sick Children
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials